(Q34421804)

2 August 2017

1 reference

title

TGF-beta signaling in cancer--a double-edged sword (English)

1 reference

2 August 2017

Akhurst RJ

1

1 reference

PubMed ID

11684442

2 August 2017

Derynck R

series ordinal

2

1 reference

2 August 2017

1 November 2001

1 reference

2 August 2017

Trends in Cell Biology

1 reference

2 August 2017

11

1 reference

2 August 2017

11

1 reference

2 August 2017

S44-51

1 reference

Growth factors from murine sarcoma virus-transformed cells

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Epithelial cell plasticity in development and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Spindle cell carcinoma.Ultrastructural evidence of squamous origin and collagen production by the tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Effects of transforming growth factor beta on growth of human mammary epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Defective angiogenesis in mice lacking endoglin

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

A murine model of hereditary hemorrhagic telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Arteriovenous malformations in mice lacking activin receptor-like kinase-1

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

A role for smad6 in development and homeostasis of the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Macrophage-derived angiogenesis factors

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor beta antibody and interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8924%2801%2902130-4

7 January 2021

10.1016/S0962-8924(01)02130-4

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11684442